Share Talk Weekly Small Cap Movers & Shakers – 15th January 2022

Another week of big moves in the resource sector was had, but that is what it is for most weeks.

Chariot Ltd. (AIM: CHAR). confirmed that a significant gas discovery was made at the Anchois-2 offshore Morocco. This materially exceeded our expectations.

Anchois-2 was drilled to a depth of 2,512m. It encountered gas accumulations with the appraisal Target, Sand B. This marked approximately 50m of net pay across two stack reservoirs. The reservoir at the top was the one seen in the original discovery well. The shares rose 61% to 11.975p after the news.

Bradda Head Lithium Ltd. (AIM: BHL). stated that preliminary metallurgical testing on samples from the Burro Creek East lithium projects indicated that extraction and production costs could be significantly reduced.

This encouraged the market, which drove the share price up 38%.

After two wealthy investors supported the company, shares in Tintra PLC, (AIM: TNT) soared 338% this week to 230p

First, Omar Mangalji’s family office in the USA, which is a Canadian Mangalji member, agreed to purchase 148,511 shares at 504p per share. The stock was trading at 53p last week, so this seems excessively high. However, the investor has the option of buying warrants at 50p each to increase its stake.

Unnamed Gulf-based strategic investors are the second investor. He subscribes for 297.022 shares at the exact same price and has the same two warrants for each ordinary share attachment.

Tintra has partnered with Time Machine Capital 2 Limited in London, an artificial intelligence investment and research company, and its affiliate Finsenr to build banking and infrastructure technology systems. These systems are focused on frontier markets and emerging markets that it feels are underserved by the current environment.

Helium One Global Ltd (AIM: HE1) shares rose 24% in the last week. This is despite zero news flow. Internet speculators are promoting what they consider an undervalued asset, the Rukwa Helium Project in Tanzania. It’s a chance to grab shares before a drill program that could be slated for later in 2022.

Helium One shares surged from 7p to 21p last year in the month that preceded a drill program. The company initiated this drill programme to provide more technical insight.

The market approved the purchase of Azinam Group Ltd from Eco (Atlantic Oil & Gas Ltd). Eco receives a substantial offshore petroleum exploration resource base in Namibia, South Africa as a result of the deal. This week, the shares rose by a third

React Group PC (LSE: REAT), jumped 39% to 2.15p after a contract win.

The company’s specialist in cleaning, hygiene, and decontamination won a long-term contract with The ExtraCare Charitable Trust. This is a prominent not-for-profit developer and operator of housing for over 55s. The business was an existing customer.

Eco Animal Health Group shares were 30% more expensive at 197.5p than they were before it suggested that there was “meaningful progress” in vaccine research and development.

The company stated that it was looking forward to sharing “exciting insights” and providing more details about the potential commercial value of our product development pipeline with existing and potential investors as well as analysts and media at Capital Markets Day.

Sensyne Health was the worst affected, losing two-thirds its value after warning that it is taking longer for prospects to become paying customers due to the COVID-19 pandemic.

The company, which specializes in clinical artificial intelligence, put itself on the market in November. It stated that it was in discussions with several parties. Friday’s slump will affect those negotiations.

Although the pandemic has helped to boost the share price for diagnostics specialist Avacta Group Plc (AIM: AVCT), the gains are quickly disappearing.

After the company stated that its AffiDX antigen testing was less sensitive to detect lower viral loads in the Omicron version of Covid-19 than the test for other forms of SARS, the shares fell by a third this week to 76.5p.

Independently, the company decided to suspend sales of the AffiDX antibody test while it replaced the antibody in the product. This was to ensure that the Omicron variant’s performance matches its high performance with other mutations.

Talking about the pandemic, it seems a while ago that panic-stricken shoppers bought toilet rolls. This was much to the advantage of Accrol Group Holdings PLC, the tissue company.

According to the company, it experienced additional inflationary pressures on input prices including pulp prices and supply chain costs. This has prompted it to lower its full-year guidance. The share price fell 29% to 22.5p.

Linking Shareholders and Executives :Share Talk

If anyone reads this article found it useful, helpful? Then please subscribe or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned

Weekly Newsletter

Sign up to receive exclusive stock market content in your inbox, once a week.

We don’t spam! Read our privacy policy for more info.